Vancouver biotech company discovering antibodies for COVID-19 treatment

Vancouver biotech company discovering antibodies for COVID-19 treatment

VANCOUVER — There may be another valuable shield in the fight against COVID-19, and the head of a Vancouver biotech firm says it could buy time as researchers race to develop a vaccine.

Carl Hansen, CEO of AbCellera Biologics Inc., said a drug built with antibodies could be used to protect vulnerable populations until a vaccine is more widely available.

The antibodies would give patients all the molecular material they need to fight the disease instead of depending on their bodies to develop their own as with a vaccine, giving them faster protection, he said.

“A prophylactic antibody could well be more effective than a vaccine,” he said.

On Sunday, Prime Minister Justin Trudeau announced $175 million federal funding for AbCellera to support its work in discovering those antibodies using a high-tech platform.

The funding also supports the company’s plans to build technology and manufacturing infrastructure for antibody therapies against future pandemic threats.

In partnership with pharmaceutical giant Eli Lilly, AbCellera is among a handful of companies on track for clinical trials this summer.

“There are many groups trying to rapidly develop vaccines for COVID-19 and vaccines are a very important part of the global response,” Hansen said.

“What we’re doing is different. What we’re doing is searching through an immune response that was generated from an actual infection and recovery in a patient and then finding that one antibody out of the literally millions that is best suited to stop the virus and that can be manufactured,” he said.

In 2012, Hansen said AbCellera recognized it could combine technologies from artificial intelligence, genomics, microfluidics and immunology to quickly search through natural immune systems to find antibodies that fight infection.

Two years ago, AbCellera began working with the Defense Advanced Research Projects Agency in the United States as part of a program to “radically accelerate” pandemic response, Hansen said. The company was working on simulations using its antibody-identifying technology when the COVID-19 pandemic struck.

“We quickly pivoted our efforts,” Hansen said.

Using blood samples from one of the first recovered COVID-19 patients in the United States on Feb. 25, AbCellera began screening millions of cells.

It narrowed down 500 unique human antibodies against the virus to a set of 24 that showed high promise of being therapeutic, he said.

“More recently we have further refined that set to a single antibody that is now being manufactured with the objective of having a first in-human trial start in July,” Hansen said.

What typically takes up to five years has been accelerated to less than four months, he said.

Vaccines and antibody-based prevention drugs work differently. With a vaccine, you inject a patient with a weakened virus or part of a virus to stimulate the immune system’s natural production of antibodies. With a prophylactic antibody, you insert the antibodies into the patient, Hansen said.

There are benefits and drawbacks. On one hand, prophylactics create more immediate protection because there’s no waiting period for the body to create its own antibodies. It’s also more broadly effective, because not all patients’ immune systems may be up to the task of producing their own antibodies.

On the other hand, a substantial number of antibodies must be administered to the patient in order to protect them.

“What that means is that the ability to manufacture hundreds of millions or even a billion doses of a vaccine is something well within the realm of possibility today. Making that many doses of antibodies is not,” he said.

That would mean giving the antibody to select groups of people at risk, such as health workers or the elderly, Hansen said.

The World Health Organization recommends that pharmacological treatment for COVID-19 should not be used outside of clinical trials.

On April 27, British Columbia’s COVID-19 therapeutics committee issued the same warning.

“There are no proven therapies for the prevention or treatment of COVID-19. All agents have the possibility of associated harm, and pharmaceutical supplies province-wide and nationally for many of the possible agents are severely limited,” it said.

For Hansen, research and development during the pandemic has not been business as usual.

“It’s not a race against our competitors nearly as much as it’s a race against the virus,” he said.

“What matters most is we get a therapy out there that works for patients and do so as quickly as possible.”

This report by The Canadian Press was first published May 5, 2020.

Amy Smart, The Canadian Press

Coronavirus

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

A nurse gets a swab ready at a temporary COVID-19 test clinic in Montreal, on Friday, May 15, 2020. Health Canada has reversed course on home test kits for COVID-19, saying it will now review applications for such devices. THE CANADIAN PRESS/Paul Chiasson
Employee at Bethany CollegeSide in Red Deer tests positive for COVID-19

An employee at a Red Deer continuing care facility has tested positive… Continue reading

The Government of Alberta has identified 1,828 new cases and 15 new COVID-19-related deaths, which brings the provincial death toll to 590. (File photo)
Alberta identifies 1,828 new COVID-19 cases on Friday

Central zone has 1,251 active cases

Higher sales of cannabis helped Canadian farmers come out in the green. (Black Press Media File)
Drumheller RCMP lay charge for unlawfully distributing cannabis

A joint forces investigation involving the AGLC investigation team partnered with Drumheller… Continue reading

Three weapons have been seized and four people are facing charges following a police operation in central Alberta. (Photo contributed by RCMP)
RCMP, Lacombe Police seize loaded guns, arrest four people

Four people have been arrested and multiple prohibited firearms are off the… Continue reading

The Salvation Army's 2020 Christmas Kettle Campaign includes a new $5 tap feature for pandemic-friendly donations. (Devon Bidal/News Staff)
Salvation Army officers safe, touchless options for Kettle donation this year

The Salvation Army in Red Deer needs help. Kettle donations are needed… Continue reading

Dan Cochrane, senior pastor at CrossRoads Church. Contributed photo
CrossRoads Church closes its doors for two weeks after staff member tests positive for COVID-19

CrossRoads Church made the decision to cancel in-house services for two weeks… Continue reading

Montreal Alouettes' Michael Sam is set to make his pro football debut as he warms up before the first half of a CFL game against the Ottawa Redblacks in Ottawa on Friday, Aug. 7, 2015. Sam became the first publicly gay player to be drafted in the NFL. He signed with the Montreal Alouettes after being released by St. Louis, but abruptly left after playing one game. THE CANADIAN PRESS/Justin Tang
Study finds Canada a “laggard” on homophobia in sports

Study finds Canada a “laggard” on homophobia in sports

Canada's Kadeisha Buchanan (3) and Mexico's Jacqueline Ovalle (11) battle for the ball during a CONCACAF women's Olympic qualifying soccer match Tuesday, Feb. 4, 2020, in Edinburg, Texas. THE CANADIAN PRESS/AP-Delcia Lopez
Lyon defender Kadeisha Buchanan named Canadian Women’s Player of the Year

Lyon defender Kadeisha Buchanan named Canadian Women’s Player of the Year

Winnipeg Blue Bombers' Andrew Harris celebrates his touchdown against the Hamilton Tiger-Cats during the first half of the 107th Grey Cup in Calgary, Alta., Sunday, Nov. 24, 2019. Running back Andrew Harris, who was instrumental in the Winnipeg Blue Bombers ending their Grey Cup drought in 2019, tops the CFL team's list of potential free agents. THE CANADIAN PRESS/Nathan Denette
Grey Cup MVP, top Canadian Harris among Winnipeg Blue Bombers potential free agents

Grey Cup MVP, top Canadian Harris among Winnipeg Blue Bombers potential free agents

24Toronto Raptors' Fred VanVleet (23) goes up for a shot agains the Boston Celtics during the first half of an NBA conference semifinal playoff basketball game in Lake Buena Vista, Fla., Friday, Sept. 11, 2020.. Watching Connor McDavid let a slapshot fly or Fred VanVleet sink a deep three can be a salve to the soul of a sports fan run down by the difficult realities of the COVID-19 pandemic. THE CANADIAN PRESS/AP-Mark J. Terrill
Bubbles are best: experts say return of sports risky as COVID-19 pandemic continues

Bubbles are best: experts say return of sports risky as COVID-19 pandemic continues

Coastal Carolina's Grayson McCall (10) scrambles past Texas State's Nico Ezidore (95) during the first half of an NCAA college football game in San Marcos, Texas, Saturday, Nov. 28, 2020. THE CANADIAN PRESS/AP-Chuck Burton
BYU presents tough challenge for Chanticleers, Canadian Makonzo this weekend

BYU presents tough challenge for Chanticleers, Canadian Makonzo this weekend

Meng Wanzhou, chief financial officer of Huawei, arrives at B.C. Supreme Court to attend a hearing, in Vancouver, on Friday, November 27, 2020. The U.S. Department of Justice is refusing to comment on media reports that its lawyers are seeking a plea deal of sorts with Chinese tech executive Meng Wanzhou. THE CANADIAN PRESS/Darryl Dyck
PM won’t confirm reports U.S. Justice Department seeking plea deal with Meng Wanzhou

PM won’t confirm reports U.S. Justice Department seeking plea deal with Meng Wanzhou

Alek Minassian is shown in a handout photo from his LinkedIn page. A psychiatrist retained by the defence will testify for a fifth consecutive day today at the trial for the man behind Toronto's van attack. Dr. Alexander Westphal says Alek Minassian does not truly understand the moral wrongfulness of killing 10 people, but says criminal responsibility is a legal opinion, not a psychiatric one. THE CANADIAN PRESS/HO
‘I know what I did was morally wrong,’ Alek Minassian told psychiatrist, court hears

‘I know what I did was morally wrong,’ Alek Minassian told psychiatrist, court hears

A look at what provinces and territories have said about COVID-19 vaccine plans

A look at what provinces and territories have said about COVID-19 vaccine plans

Most Read